About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 2

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

NCT01614990•Garcia, Jose M., MD, PhD

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Cancer Cachexia

Interventions

Macimorelin

Placebo

Locations

1

United States

Locations (1)

Veterans Affairs Puget Sound Health Care System

Seattle, Washington, United States

Key Dates

Start Date

May 1, 2012

Primary Completion Date

July 1, 2020

Completion Date

December 1, 2021

Last Updated

March 20, 2024

Related Studies

RECRUITINGPhase 2

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT07072728

Adjustment DisorderAdjustment Disorder With Anxious Mood+9 more

RECRUITINGPhase 1

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants

NCT07237464

Cancer Cachexia (CC)Cancer Cachexia+1 more

RECRUITINGPhase 2

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

NCT07033026

Colorectal CancerCRC (Colorectal Cancer)+1 more

RECRUITINGPhase 1

A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia

NCT06898255

Cancer Cachexia

COMPLETEDPhase 2

The Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Head and Neck Cancer

NCT04208334

Cancer CachexiaHead and Neck Cancer+1 more

Medical Imaging of Cachexia

NCT04127981

Cancer Cachexia

View all related studies

Sponsors

Lead Sponsor

Garcia, Jose M., MD, PhD

Collaborators

VA Office of Research and Development
Baylor College of Medicine
AEterna Zentaris

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 20, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions